CALCULATE YOUR SIP RETURNS

Emcure Pharmaceuticals Unveils Advanced R&D Centre in Gujarat

Written by: Team Angel OneUpdated on: Jan 23, 2025, 3:30 PM IST
Emcure Pharmaceuticals inaugurates a world-class R&D centre in Gujarat to enhance pharmaceutical innovation, sustainability, and patient care globally.
Emcure Pharmaceuticals Unveils Advanced R&D Centre in Gujarat
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

January 23, 2025, Emcure Pharmaceuticals, a leading name in the Indian pharmaceutical sector, marked a significant milestone by inaugurating its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, Ahmedabad, Gujarat. This facility, aptly named the Emcure Research Centre (ERC), underscores the company’s commitment to advancing healthcare through cutting-edge drug delivery systems and innovative formulations.

Emcure Pharmaceuticals’ share price was trading marginally down by 0.17% on the NSE as of 2:05 PM on January 23, 2025.

A World-Class Facility for Transformative Research

The ERC is equipped with advanced laboratories and technology to enable breakthroughs in complex drug delivery systems, including sustained-release formulations, liposomal injections, and dermal therapies. By seamlessly integrating all aspects of pharmaceutical development—from pre-formulation to scale-up—the facility adheres to stringent global regulatory standards, setting a benchmark for excellence in pharmaceutical research.

Empowering Talent and Enhancing Patient Care

A dedicated team of 350 skilled professionals, comprising doctorate holders, postgraduates, and graduates from various fields like pharmaceutical sciences, bio-engineering, and regulatory affairs, will drive research initiatives at ERC. Their focus is on creating patient-centric solutions, improving drug bioavailability, and developing innovative formulations that address unmet medical needs.

Promoting Sustainability and Collaboration

Reflecting Emcure’s dedication to environmentally conscious practices, the ERC prioritises green chemistry and sustainable solutions. Moreover, the centre aims to foster collaborations with academic institutions, industry experts, and regulatory bodies, thereby creating an ecosystem of shared knowledge and innovation. This initiative not only boosts pharmaceutical advancements but also generates employment opportunities, strengthening Gujarat’s position as a hub for pharmaceutical research.

A Message from Gujarat’s Health Minister

Shri Rushikeshbhai Patel, Honourable Minister of Health and Family Welfare, Government of Gujarat said, “It gives me great pride to inaugurate Emcure Pharmaceuticals’ advanced R&D centre in Ahmedabad. Gujarat has always been a hub for innovation and progress, and this facility is a shining example of how we can create futuristic healthcare solutions. By investing in drug research and nurturing local talent, Emcure is not only contributing to Gujarat’s growth but also strengthening India’s position as a global leader in pharmaceuticals. I compliment the entire team at Emcure for this remarkable achievement”.

Emcure’s Vision for the Future

“Over the past four decades, Emcure has remained steadfast in its commitment to pushing the boundaries of pharmaceutical research and development, creating innovative solutions for unmet medical challenges”, said Mr. Satish Mehta, Founder and CEO, of Emcure Pharmaceuticals. “This new R&D centre represents a significant milestone in our continued pursuit of innovation, by combining advanced research technology with a talented team. With a focus on both efficiency and quality, the centre is set to drive advancements that will reshape the future of medicine globally”, he concluded.

About Emcure Pharmaceuticals

Established in 1981 and headquartered in Pune, Emcure Pharmaceuticals ranks as the 12th largest pharma company in India by domestic sales (MAT June 2024). Operating in over 70 countries, including Europe and Canada, the company is renowned for its innovation, quality, and patient-centric approach across a broad range of therapeutic areas.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Jan 23, 2025, 3:30 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2.5 Cr+ happy customers